Public expenditure on blue prescriptions in Norway 2013-2018

The public expenditure on blue prescriptions in Norway fluctuated during the period from 2013 to 2018. In 2015, it reached a peak, with a public expenditure of 12.5 billion Norwegian kroner. In 2018, it amounted to 11.8 billion Norwegian kroner.

Public expenditure on blue prescriptions* in Norway from 2013 to 2018

Exclusive Premium statistic

You need a Premium Account for unlimited access.

  • Full access to 1m statistics

  • Incl. source references

  • Available to download in PNG, PDF, XLS format

Premium Account

only $59 / month *
*Duration: 12 months, billed annually, single license

Access to this and all other statistics on 80,000 topics from

$708 / Year

Show detailed source information?
Register for free
Already a member?
Log in

Release date

April 2019



Survey time period

2013 to 2018

Supplementary notes

The definition of blue prescription according to the European commission: "If the medication is on a blue prescription, the patient pays a co‑payment of 39 percent of the cost of the prescription, up to 520 Norwegian kroner per prescription. Children under the age of 16 and pensioners receiving the minimum pension do not have to pay any co-payment."

Statista Accounts: Access All Statistics. Starting from $708 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account!

Premium Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$59 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.

Statistics on "Pharmaceutical industry in Norway "

Further Content: You might find this interesting as well

Statista Accounts: Access All Statistics. Starting from $708 / Year
Learn more about how Statista can support your business.